Hamps Bio Makes Debut on BSE SME; Lists with 90% Premium

A Gujarat-based pharmaceutical and FMCG company, Hamps Bio share price, made a debut on the Bombay Stock Exchange (BSE), listing at ₹96.9 per share, a 90% premium over its IPO price of ₹51.

The Hamps Bio ₹6.2-crore public issue, which opened for subscription on December 13, was subscribed 1,057 times by the end of the third day of bidding.

Objects of the Issue

The funds raised through the IPO will be utilised for purchasing plant and machinery for its FMCG division, increasing brand awareness, and general corporate purposes. This strategic move aims to bolster the company’s manufacturing capabilities and enhance its market presence.

About Hamps Bio 

The company operates in the marketing and distribution of pharmaceutical formulations and also manufactures freeze-dried and frozen products.

Its product portfolio is distributed through a network of over 50 distributors and leading e-commerce platforms such as Amazon, Flipkart, and JioMart. The company primarily sells its pharma products in eight states and union territories across India.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. It is based on several secondary sources on the internet and is subject to changes. Please consult an expert before making related decisions.